| Code | 93174 | ||||||||||
| MA number | 16/0226/13-S | ||||||||||
| Product Form: | plv iio 1x1000 IU+20 ml solv.(liek.skl.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | Baxalta Innovations GmbH, Austria | ||||||||||
| Therapeutic Class: | 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 12.04.1989 |
| Pediatric warnings: | Yes |
| SPC: |
SPC_ANTITHROMBIN III BAXALTA 1000 IU_10.2024.pdf
|
| PIL: |
PIL_ANTITHROMBIN III BAXALTA 500 IU_1000 IU_10.2024.pdf
|
| Safety feature | Yes |
| Data update: | 21.12.2018 |
